National Vaccine Injury Compensation Program Data Report - October 3, 2016 (PDF - 216 KB)
Updated monthly, and includes the number of:
The United States has the safest, most effective vaccine supply in history. In the majority of cases, vaccines cause no side effects, however they can occur, as with any medication—but most are mild. Very rarely, people experience more serious side effects, like allergic reactions.
In those instances, the National Vaccine Injury Compensation Program (VICP) allows individuals to file a petition for compensation.
What does it mean to be awarded compensation?
Being awarded compensation for a petition does not necessarily mean that the vaccine caused the alleged injury. In fact:
What reasons might a petition result in a negotiated settlement?
How many petitions have been awarded compensation?
According to the CDC, from 2006 to 2014 over 2.5 billion doses of covered vaccines were distributed in the U.S. For petitions filed in this time period, 3,610 petitions were adjudicated by the Court, and of those 2,277 were compensated. This means for every 1 million doses of vaccine that were distributed, 1 individual was compensated.
Since 1988, over 17,437 petitions have been filed with the VICP. Over that 27 year time period, 15,040 petitions have been adjudicated, with 4,954 of those determined to be compensable, while 10,086 were dismissed. Total compensation paid over the life of the program is approximately $3.4 billion.
The Latest Statistics
Read the current statistics report - updated as of October 3, 2016.
The content of this website reflects the current thinking of the United States Department of Health and Human Services on the topics addressed and does not create or confer any rights for or on any person and does not operate to bind the Department or the public. The ultimate decision about the scope of the statutes authorizing the VICP is within the authority of the United States Court of Federal Claims, which is responsible for resolving petitions for compensation under the VICP.
Last Reviewed: September 2016